Detection of relapse following allogeneic stem cell transplantation in AML:: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism

被引:0
|
作者
Bacher, U. [1 ]
Badbaran, A. [1 ]
Fehse, B. [1 ]
Zabelina, T. [1 ]
Zander, A. R. [1 ]
Kroeger, N. [1 ]
机构
[1] Univ Hamburg, Clin Stem Cell Transplant, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [1] A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, Miguel
    Bertz, Hartmut
    Finke, Juergen
    ANNALS OF HEMATOLOGY, 2014, 93 (02) : 293 - 298
  • [2] Quantitative monitoring of NPM1 mutations versus chimerism for detection of impending relapse after allogeneic stem cell transplantation in AML
    Bacher, U.
    Badbaran, A.
    Fehse, B.
    Zabelina, T.
    Lehmann, F.
    Zeschke, S.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S335 - S335
  • [3] A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation
    Miguel Waterhouse
    Hartmut Bertz
    Juergen Finke
    Annals of Hematology, 2014, 93 : 293 - 298
  • [4] A simple, one step assay for simultaneous detection of haematopoietic chimerism, NPM1 and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, M.
    Bertz, H.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S244 - S245
  • [5] A simple, one step assay for simultaneous detection of hematopoietic chimerism, NPM1 and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, M.
    Bertz, H.
    Finke, J.
    ONKOLOGIE, 2012, 35 : 127 - 127
  • [6] Response: Allogeneic stem cell transplantation and FLT3/ITD status in AML
    Gale, Rosemary E.
    Hills, Robert
    Wheatley, Keith
    Burnett, Alan K.
    Linch, David C.
    BLOOD, 2006, 108 (01) : 400 - 401
  • [7] PCR-based MRD detection in AML with normal karyotype or other intermediate risk aberrations by the use of FLT3-LM, NPM1-mutations, MLL-PTD or WT1-overexpression.
    Schnittger, Susanne
    Schoch, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2006, 108 (11) : 651A - 651A
  • [8] Allogeneic stem cell transplantation for patients with AML and FLT-3 mutations
    Schleuning, M.
    Judith, D.
    Heshmat, M.
    Burlakova, I.
    Tschischka, S.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S274 - S275
  • [9] Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML
    Meshinchi, Sohell
    Arceci, Robert J.
    Sanders, Jean E.
    Smith, Franklin O.
    Woods, William B.
    Radich, Jerald R.
    Alonzo, Todd A.
    BLOOD, 2006, 108 (01) : 400 - 400
  • [10] Simultaneous Detection of FLT3-ITD, FLT3-D835 and NPM1 Mutations in AML
    Bernardino, L. P.
    Nagy, P. L.
    Hensel, J. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 578 - 578